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Adhesive contact between pre- and postsynaptic
neurons initiates synapse formation during brain
development and provides a natural means of trans-
synaptic signaling. Numerous adhesion molecules
and their role during synapse development have
been described in detail. However, once established,
the mechanisms of adhesive disassembly and its
function in regulating synaptic transmission have
been unclear. Here, we report that synaptic activity
induces acute proteolytic cleavage of neuroligin-1
(NLG1), a postsynaptic adhesion molecule at gluta-
matergic synapses. NLG1 cleavage is triggered by
NMDA receptor activation, requires Ca2+/calmod-
ulin-dependent protein kinase, and is mediated by
proteolytic activity of matrix metalloprotease 9
(MMP9). Cleavage of NLG1 occurs at single activated
spines, is regulated by neural activity in vivo, and
causes rapid destabilization of its presynaptic
partner neurexin-1b (NRX1b). In turn, NLG1 cleavage
depresses synaptic transmission by abruptly
reducing presynaptic release probability. Thus, local
proteolytic control of synaptic adhesion tunes
synaptic transmission during brain development
and plasticity.
INTRODUCTION
Neuronal synapses are maintained by a complex network of
adhesion molecules that span the synaptic cleft and juxtapose
the presynaptic active zone with the postsynaptic density (Dalva
et al., 2007). The tight association between pre- and postsyn-
aptic elements has long suggested that changes on either side
of the synapse are transmitted trans synaptically (Lisman and
Harris, 1993). Indeed, postsynaptic receptor blockade augments
presynaptic function through unknown mechanisms (Burrone396 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.et al., 2002; Murthy et al., 2001; Thiagarajan et al., 2005; Wier-
enga et al., 2006), whereas increased activity in dendritic
segments retrogradely dampens release probability of con-
tacting presynaptic terminals (Branco et al., 2008). Given their
confined localization at synapses and restricted number of
interactions, postsynaptic adhesionmolecules offer the potential
for tight local control over presynaptic function (Futai et al., 2007;
Gottmann, 2008; Ko et al., 2009; Missler et al., 2003; Restituito
et al., 2011; Stan et al., 2010). However, whether transsynaptic
adhesion acutely regulates synapse function is unclear.
Neuroligins (NLGs) are postsynaptic adhesion molecules
that bind presynaptic neurexins (NRXs) with nanomolar affinity
(Su¨dhof, 2008). Rodents have four NLG isoforms, each exhibiting
a specific expression pattern and subcellular distribution. In
particular, NLG1 and NLG2 are localized to excitatory and inhib-
itory synapses, respectively (Graf et al., 2004). NLGs and NRXs
contain intracellular domains that interact with scaffold proteins,
such as PSD95 and CASK (Su¨dhof, 2008). Adhesion between
NLGs and NRXs thus provides a structural bridge between
pre- and postsynaptic scaffolding machinery. In humans, NRXs
and NLGs have been strongly linked to autism spectrum dis-
orders, emphasizing the importance of this transsynaptic
complex for normal brain development (Su¨dhof, 2008). Indeed,
NLGs induce functional maturation of presynaptic terminals
(Dean et al., 2003; Scheiffele et al., 2000; Wittenmayer et al.,
2009), whereas NRXs cluster postsynaptic proteins (Graf et al.,
2004; Heine et al., 2008).
Their ability to transaggregate synaptic components impli-
cated NLGs and NRXs as critical mediators of synapse forma-
tion. This hypothesis was supported by in vitro studies showing
that NLG levels correlate with the number of synapses generated
during development (Chih et al., 2005; Dean et al., 2003; Graf
et al., 2004; Levinson et al., 2005). However, NLG1-NLG3 triple
knockout (KO) neurons exhibit normal synapse number and
ultrastructural synaptic features, but present severe deficits in
synaptic transmission (Varoqueaux et al., 2006), indicating
that, in vivo, NLGs are not required for the initial stages of synap-
togenesis, but are critical for proper synaptic function. Recent
studies have further shown that NLGs regulate NMDA (Chubykin
et al., 2007; Jung et al., 2010) and AMPA (Etherton et al., 2011;
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MMP9 Cleaves Neuroligin at SynapsesHeine et al., 2008; Shipman et al., 2011) receptor function and
are involved in multiple forms of synaptic plasticity across
species (Choi et al., 2011; Jung et al., 2010).
Interestingly, overexpression of NLG1 in hippocampal slices
and cultured neurons increases release probability through
NRX-dependent mechanisms (Futai et al., 2007; Ko et al.,
2009; Stan et al., 2010), whereas disruption of endogenous
NLG-NRX interactions with soluble Fc-NRX fragments
decreases miniature excitatory postsynaptic current (mEPSC)
frequency and release probability (Levinson et al., 2005). In vivo,
transgenic expression of NLG1 results in extended active zones
and increased number of reserve pool vesicles (Dahlhaus et al.,
2010), while neurons lacking aNRX1-aNRX3 exhibit deficits in
synaptic transmission due to impaired N-type Ca2+ channel
function (Missler et al., 2003). These results suggest that the
NLG-NRX transsynaptic complex is an important regulator of
presynaptic function. However, a limitation of most studies to
date is the reliance on long-term manipulations susceptible
to indirect compensatory mechanisms. High frequency stimula-
tion of cultured hippocampal neurons induces fast morpholog-
ical changes of NLG1 puncta (Gutie´rrez et al., 2009), indicating
that NLG1 can be acutely regulated by activity. Yet, the under-
lying mechanisms, activity-dependent signals, and functional
consequences of acute NLG1 regulation at synapses remain
unknown.
MMPs are a large family of secreted Zn2+-dependent proteo-
lytic enzymes that cleave extracellular matrix components and
pericellular proteins. MMP2, MMP3, and MMP9 are highly
abundant in the brain and have been associated with synapto-
genesis, synaptic plasticity, and multiple neuropathological
conditions (Ethell and Ethell, 2007; Yong, 2005). In particular,
MMP9 is acutely upregulated and secreted in response to
neuronal activity and is required for the expression of long-
term potentiation (Bozdagi et al., 2007; Nagy et al., 2006;
Wang et al., 2008). Moreover, MMP9 activity is increased
following epileptic seizures in the hippocampus and is required
for postseizure synaptic plasticity and circuit remodeling
(Szklarczyk et al., 2002; Wilczynski et al., 2008). Despite a well-
documented role in regulating synapse function and plasticity
(Bozdagi et al., 2007; Michaluk et al., 2009; Nagy et al., 2006),
the substrates of MMP9 associated with functional remodeling
of glutamatergic synapses remain unclear.
In the present study, we demonstrate that synaptic activity
triggers rapid MMP9-mediated proteolysis of synaptic NLG1.
Cleavage of NLG1 is ubiquitous in the brain, occurs throughout
development, and is upregulated by neuronal activity in mature
and developing circuits. Using a combination of biochemical,
live cell imaging, and electrophysiological analysis, we show
that postsynaptic cleavage of NLG1 occurs at single activated
dendritic spines, requires NMDA receptor and Ca2+-calmod-
ulin-dependent kinase (CaMK) signaling, and causes rapid
destabilization of presynaptic NRX1b. Acute NLG1 cleavage in
turn suppresses synaptic strength by rapidly reducing presyn-
aptic release probability. Together, our results indicate that
postsynaptic activity influences presynaptic function by NLG1
cleavage, revealing a posttranslational mechanism of NLG1
regulation that contributes to synapse plasticity in vivo.
Activity-dependent cleavage of synaptic adhesion complexesmay provide a general paradigm for transsynaptic signaling in
diverse neural circuits.
RESULTS
Neuronal Activity Induces Rapid Loss of Synaptic NLG1
To determine the effect of neuronal activity on synaptic NLGs,
we treated dissociated 21 days in vitro (DIV21) cortical cultures
with 30 mM KCl for 2 hr. Endogenous NLG levels were assessed
by immunocytochemistry using a pan-NLG antibody directed
against the C-terminal domain of NLG1-NLG4. PSD95 immuno-
labeling was used to identify glutamatergic synapses. Following
KCl treatment, pan-NLG levels at PSD95-positive dendritic
spines were reduced by 29.5% ± 5.3% relative to control
(Figures 1A and 1B). A similar change was observed in total
pan-NLG levels (28.9% ± 1.1% decrease after KCl), indicating
a net loss of NLGs across the entire cell (Figure 1B). NLG1
predominantly partitions to and regulates glutamatergic
synapses (Chubykin et al., 2007; Graf et al., 2004). The loss of
NLGs from PSD95-positive sites prompted us to test whether
depolarization depletes NLG1 from the postsynaptic density
(PSD). Due to the lack of NLG1-specific antibodies suitable for
immunocytochemistry, we performed biochemical fractionation
of DIV21 cortical cultures after KCl stimulation (Ehlers, 2003)
and measured NLG1 levels using an antibody targeted against
the extracellular N-terminal domain. Immunoblot analysis of iso-
lated fractions revealed enrichment of NLG1 in the PSD (Fig-
ure S1 available online). KCl depolarization resulted in a signifi-
cant loss (47.6% ± 1.8%) of NLG1 from total extracts (Figures
1C and 1D). This reduction in NLG1 was observed in both
synaptic plasma membrane (SPM) and PSD fractions (30.5% ±
1.5% decrease in SPM; 23.9% ± 7.3% in PSDI; 45.1% ± 5.4%
in PSDIII) and was particularly pronounced in Triton-insoluble
PSDII fractions (72.9% ± 4.9% reduction), in which NLG1 is
most highly enriched (Figure S1).
We next tested whether KCl incubation increases NLG1
internalization and lysosomal degradation using surface bio-
tinylation (Ehlers, 2000). To inhibit lysosomal proteolysis, cells
were preincubated with leupeptin for 1 hr. In basal conditions,
5.3% ± 1.2% of surface NLG1 was internalized over 2 hr
(Figures 1E and 1F). This low internalization rate was unaltered
by KCl (5.7% ± 0.8% of surface NLG1 internalized), indicating
that KCl-induced NLG1 loss is not due to increased internaliza-
tion. By contrast, the GluA1 receptor exhibited a marked
increase in internalization upon KCl stimulation (Figure 1F, right
panel), similar to previous reports (Ehlers, 2000). We further
addressed whether KCl-induced loss of total NLG1 was sensi-
tive to proteasome or lysosome inhibition. Incubation with
KCl for 2 hr resulted in a 48.1% ± 2.6% reduction of total
NLG1 levels, which was unaffected by proteasome inhibition
(MG132, 50 mM), blockade of lysosomal degradation (leupeptin,
200 mM), or both together (MG132, 51.5% ± 5.7%; leupeptin,
46.3% ± 6.7%; both, 47.4% ± 4.2% of control; Figures 1G
and 1H). However, incubation with the broad-spectrum MMP
inhibitor GM6001 (10 mM) abolished KCl-induced loss of
NLG1 (102.9 ± 1.1% of control; Figures 1G and 1H), whereas
incubation with GM6001, MG132, or leupeptin alone did not
significantly alter NLG1 levels under basal conditions (MG132,Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc. 397
Figure 1. Neuronal Activity Triggers Loss of
Neuroligin-1 from Synapses
(A) Hippocampal neurons (DIV21) incubated in
media (control) or media with 30 mM KCl for 2 hr
(KCl) immunolabeled for PSD95 and pan-NLG
(NLG1–NLG4). Arrows show NLG1–NLG4 labeling
at PSD95-positive synapses under control condi-
tions (open) or after KCl (solid). Boxed regions are
magnified in lower panels. Scale bars, 5 mm and
1 mm.
(B) Means ± SEM of NLG1–NLG4 fluorescence
intensity in PSD95-positive spines (left) or entire
neurons (right) normalized to controls. Control, n =
435 puncta, 8 neurons; KCl, n = 546 puncta, nine
neurons. *p < 0.01.
(C) Immunoblot analysis of NLG1 in membrane
fractions isolated from control (Ctrl) or KCl-
treated cortical neurons (DIV21). EXT, whole cell
extract; SPM, synaptic plasma membrane;
PSDI,II, III; postsynaptic density fractions. Note
that 4-fold less protein by mass was loaded in
PSD fraction lanes. See Experimental Procedures
for details.
(D) Means ± SEM of NLG1 protein levels relative
to EXT control. n = 3, *p < 0.05, **p < 0.005, ***p <
0.001.
(E) Biotinylation assay of endocytosis performed
on DIV21 cortical neurons incubated in media
(Ctrl) or media with 30 mM KCl. Surf, total surface
protein at time zero. See Experimental Procedures
for details.
(F) Quantitative analysis of NLG1 (left) and GluA1
(right) internalization over time.
(G) Immunoblot of NLG1 in lysates of DIV21
cortical cultures following 2 hr incubation in
medium (Ctrl) or medium with 30 mM KCl alone
or supplemented with MG132 (10 mM), leupeptin (200 mM), leupeptin+MG132 (Leup/MG), or GM6001 (10 mM). Note that GM6001 prevents KCl-induced loss
of total NLG1.
(H) Means ± SEM of total NLG1 under indicated conditions. n = 3, *p < 0.05.
See also Figure S1.
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MMP9 Cleaves Neuroligin at Synapses103.6% ± 4.4%; leupeptin, 102.1% ± 0.8%; GM6001, 109.8% ±
5.1% of control; Figures S1B and S1C).
Juxtamembrane Cleavage of Neuroligin-1 Releases Its
N-Terminal Ectodomain
To test whether NLG1 is cleaved at the plasma membrane, we
developed an assay based on surface biotinylation (Figure 2A).
Briefly, DIV21 neuronal cultures were covalently labeled with
cell impermeable biotin (Sulfo-LC-Biotin-NHS, 1 mg/ml) to
exclusively label surface proteins. Following incubation at
37C, culture media was collected, centrifuged, and incubated
overnight with streptavidin beads to isolate released soluble
biotin conjugates prior to immunoblot analysis. Using this assay,
we detected accumulation of 90 kDa soluble polypeptide(s)
recognized by N-terminal NLG1 antibody in the media (Fig-
ure 2B). To control for possible artifacts generated by bio-
tinylation, we filtered media from unbiotinylated neuronal
cultures using a 30 kDa cutoff filter, and similar 90 kDa bands
were detected in the concentrated fractions (Figure S2A). Initially
postulated as breakdown products (Ichtchenko et al., 1995),
90 kDa NLG1 species have been widely observed and con-
sidered to be immature unglycosylated forms of NLG1 (Ko398 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.et al., 2009; Scheiffele et al., 2000). To test whether 90 kDa
NLG1 polypeptide(s) correspond to immature or incompletely
glycosylated isoforms, we enzymatically deglycosylated N-
and O-linked glycans from media-collected biotinylated frac-
tions and examined electrophoretic mobility. Deglycosylation
resulted in equivalent migration shifts of full length and soluble
90 kDa NLG1 species (Figure 2C), identifying the latter as
cleaved NLG1 N-terminal fragments (NLG1-NTFs) rather than
immature nonglycosylated species.
To determine if NLG1 is cleaved in vivo, we analyzed soluble
fractions of cortical, hippocampal, and cerebellar tissue from
adult P60 mice (Figure 2D). Several NLG1 bands of 90 kDa
were present in all brain fractions, indicating that multiple
cleavage fragments are generated in vivo. Enzymatic deglyco-
sylation of these fractions also resulted in a migration shift of
NLG1-NTFs, indicating that they originate from mature forms
of NLG1 (Figures 2E and S2B). To exclude possible antibody
nonspecificity, we tested whether similar bands were detected
in extracts of NLG1 KO mice (Varoqueaux et al., 2006). Both
110 kDa full form and 90 kDa NLG1-NTFs were absent in
NLG1 KO brain extracts and respective soluble fractions
(Figure 2F), confirming that the NTFs detected correspond to
Figure 2. A Soluble N-Terminal Fragment of
NLG1 Is Abundant in Brain
(A) Diagram of biotinylation-based cleavage
assay. Media from surface biotinylated neuronal
cultures was collected and soluble biotin conju-
gates isolated by streptavidin precipitation.
(B) Immunoblot analysis of NLG1 reveals time-
dependent release of soluble 90 kDa NLG1-
NTFs to culture media. Lys, 10% total surface
protein at time zero.
(C) Deglycosylation induces an equivalent
mass shift of both full-length NLG1 (Lysate) and
NLG1-NTFs (Media) collected after surface bio-
tinylation.
(D) Immunoblot analysis of NLG1 in whole
homogenates (5 mg, Total) and soluble (50 mg, Sol)
fractions obtained from cortical, hippocampal,
and cerebellar tissue from P60 WT mice reveals
soluble 90 kDa NLG1-NTFs.
(E) Deglycosylation of whole homogenates (Total)
and soluble fractions from P5 WT mouse cortex
results in an 20 kDa apparent mass shift of
NLG1-NTFs.
(F) Immunoblot analysis of NLG1 in whole brain
homogenates (Total) and soluble fractions (Sol)
from WT and NLG1-KO mice reveals absence of
NLG1-NTFs in NLG1-KO tissue.
(G) Developmental profile of NLG1-NTFs from
WT mouse cortical extracts at different postnatal
days (P). Total, 10 mg whole cortical homogenates;
Sol, 50 mg soluble fractions.
(H) Line scan analysis of immunoblots shown in (G). Note that the relative abundance of NLG1-NTFs is higher during early developmental stages. The graph plots
normalized signal intensity along the lines shown on the blots on the left.
(I) Immunoblot analysis of NLG1-CTFs in total homogenates (Total), soluble fractions (Sol), and membrane fractions (Memb) from P60 WT mouse cortex.
(J) Immunoblot analysis of NLG1-CTFs inwhole brain homogenates fromWT andNLG1-KOmice reveals the absence of20 kDaNLG1-CTFs in NLG1-KO tissue.
See also Figure S2.
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MMP9 Cleaves Neuroligin at Synapsescleaved NLG1. To characterize the developmental profile of
NLG1 cleavage, we performed immunoblot analysis of mouse
cortical fractions from birth to adulthood (P1–P60, Figure 2G).
Interestingly, NLG1-NTFs are present throughout development
and are enriched during the first postnatal week (P1–P7), where
they are as abundant as full-length NLG1 (Figures 2G and 2H).
A logical outcome of N-terminal proteolysis is the generation
of corresponding intracellular C-terminal fragments (CTFs).
Analysis of mouse cortical fractions using an antibody targeted
against the C-terminal domain of NLG1 revealed multiple
membrane-associated 20 kDa species, a size consistent with
the predicted mass of NLG1-CTFs based on the size of NLG1-
NTFs (Figure 2I). These bands are absent in NLG1-KO brain
extracts, confirming that they correspond to NLG1 fragments
(Figure 2J). To confirm these findings, we expressed a dually
tagged version of NLG1 with N-terminal green fluorescent
protein (GFP) and C-terminal hemagglutinin (HA) (GFP-NLG1-
HA) in COS7 cells. Immunoblot analysis of cell extracts using
an anti-HA antibody revealed the presence of 20 kDa bands
in lysates from cells expressing GFP-NLG1-HA, but not GFP-
NLG1 (Figure S2C).
Neuronal Activity Induces Cleavage of Neuroligin-1
through an NMDAR-CaMK-MMP9 Signaling Pathway
Combining our biotinylation-based assay with pharmacological
manipulation of DIV21 cortical neuron cultures, we assessedhow neuronal activity regulates NLG1 cleavage. Whereas pre-
venting action potentials with tetrodotoxin (TTX, 2 mM)
decreased NLG1-NTFs (0.65 ± 0.06 of control), increasing
network activity with bicuculline (50 mM) and 4-aminopyridine
(4AP, 25 mM) significantly increased NLG1 cleavage (Bic/4AP,
NLG-NTF levels: 1.5 ± 0.1 of control; Figures 3A and 3B). To
mimic conditions that induce robust loss of synaptic NLG1
(Figure 1), we depolarized neurons with 30 mM KCl for 2 hr.
Depolarization led to a pronounced increase in NLG1-NTFs
(4.4 ± 0.5-fold) compared to control conditions (Figures 3C and
3D). This effect was abrogated by the NMDA receptor antagonist
APV (50 mM, 1.0 ± 0.2 of control), whereas APV alone induced
no change in NLG1-NTF levels under basal conditions (APV,
0.95 ± 0.1 of control; Figure S3A and S3B). Moreover, brief
5 min incubation with 50 mM NMDA induced a robust increase
in NLG1-NTFs, indicating that NMDA receptor activation is
both necessary and sufficient to trigger NLG1 cleavage. By
contrast, the selective AMPA receptor antagonist NBQX
(20 mM) failed to abrogate KCl-induced cleavage (NMDA, 2.4 ±
0.1; KCl+NBQX, 1.92 ± 0.1; NBQX, 1.37 ± 0.1; Figures S3A
and S3B). In addition, CaMK inhibitors KN93 (5 mM) and KN62
(10 mM), but not the inactive isomer KN92 (5 mM) also abrogated
KCl-induced increase in NLG1-NTFs (KN93, 1.5 ± 0.3; KN62,
1.5 ± 0.4; KN92, 5.0 ± 0.8-fold increase in NLG1-NTFs relative
to control; Figures 3C and 3D), indicating that activity-dependent
NLG1 cleavage is further regulated by CaMK signaling.Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc. 399
Figure 3. Neuronal Activity Induces NLG1 Cleavage through NMDAR, CaMK, and MMP9 Signaling
(A) Isolation and detection of NLG1-NTFs under control conditions or in the presence of TTX (2 mM) or bicuculline (50 mM) plus 4AP (25 mM, Bic/4AP). Surface, 10%
of total surface protein at time zero.
(B) Means ± SEMs of NLG1-NTFs under indicated conditions normalized to control. n = 4, *p < 0.05.
(C) Isolation and detection of NLG1-NTFs under control conditions or in the presence of KCl (30 mM, 2 hr) with or without indicated pharmacological agents.
(D) Means ± SEMs of NLG1-NTFs levels normalized to control. n = 4, *p < 0.05, **p < 0.01.
(E) Isolation and detection of90 kDa NLG1-NTFs under control conditions or in the presence of KCl with or without MMP inhibitors. Note that inhibitors targeting
MMP9 abrogate KCl-induced NLG1 cleavage.
(F) Means ± SEMs of NLG1-NTFs levels normalized to control. n = 8, *p < 0.005. n.s., not significant.
(G) Immunoblot analysis of NLG1 and NLG1-NTFs in biotinylated fractions of DIV21 cortical neurons treated with the nonselective MMP activator APMA with or
without MMP inhibitors. Lys, whole lysates; Med, media. Note that only 10% of precipitate was loaded in Lys lanes.
(H) Means ± SEMs of NLG1-NTFs produced under the indicated conditions normalized to control. n = 3, *p < 0.05.
(I and J) Immunoblot analysis of NLG1 in whole cell extracts from DIV18 cortical neuron cultures from (I) WT or (J) MMP9 KO mice following 2 hr incubation in
neurobasal medium (control) or mediumwith 30mMKCl (KCl). Bar graphs on the right represent means ± SEM of total NLG1 levels under the indicated conditions
for WT (n = 6, *p < 0.01) and MMP9 KO neurons (n = 6, p > 0.05), respectively.
See also Figure S3.
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MMP9 Cleaves Neuroligin at SynapsesWhat enzyme is responsible for NLG1 cleavage? Using
biotinylation-based isolation of NLG-NTFs, we found that the
broad spectrum MMP inhibitor GM6001 (10 mM) prevented
activity-induced cleavage of NLG1 (fold increase relative to
control: KCl, 2.5 ± 0.2; KCl + GM6001, 0.8 ± 0.2; Figures 3E
and 3F). MMP2, MMP3, and MMP9 are the most abundant
MMPs in the brain and have been implicated in several forms
of synaptic plasticity (Ethell and Ethell, 2007; Yong, 2005).
Incubation with MMP2/MMP9 inhibitor II (0.3 mM) or MMP9/
MMP13 inhibitor I (20 nM) blocked KCl-induced NLG1 cleavage
(NLG1-NTFs relative to control: KCl + MMP2/MMP9i, 0.6 ± 0.1;400 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.KCl +MMP9/MMP13i, 0.4 ± 0.1; Figures 3E and 3F). Importantly,
the selective MMP2 inhibitor III (50 mM), or MMP13 inhibitor I
(0.5 mM) had no significant effect on NLG1 cleavage (NLG1-
NTFs relative to control: KCl + MMP2i, 2.5 ± 0.1; KCl +
MMP13i 2.7 ± 0.4; Figures 3E and 3F). Interestingly, GM6001,
MMP2/MMP9 inhibitor I, and MMP9/MMP13 inhibitor I, but
not MMP2 inhibitor III, MMP3 inhibitor III, or MMP13 inhibitor I
also reduced NLG1 cleavage under basal conditions (NLG1-
NTFs relative to control: GM6001, 0.46 ± 0.09; MMP2i, 0.85 ±
0.13; MMP3i, 0.94 ± 0.13; MMP2/MMP9i, 0.47 ± 0.11; MMP9/
MMP13i, 0.27 ± 0.11; MMP13i, 0.92 ± 0.15; Figures S3C and
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MMP9 Cleaves Neuroligin at SynapsesS3D), indicating that MMP9-dependent cleavage is active not
only during periods of elevated neuronal activity, but also under
basal conditions. Moreover, we noted that MMP3 inhibitor III
(50 mM) induced a partial but nonsignificant decrease in NLG1-
NTFs after KCl (KCl + MMP3i, 1.7 ± 0.1, p = 0.092; Figures 3E
and 3F). MMPs are secreted as inactive zymogens and require
cleavage of their prodomains to become enzymatically active
(Ethell and Ethell, 2007). Thus, the effect of MMP3 inhibition
could be due to impaired MMP9 activation. To determine
which MMP is the terminal protease-cleaving NLG1, we treated
neurons with 4-aminophenylmercuric acetate (APMA), a com-
pound that nonselectively activates all MMPs by cleaving their
prodomains (Van Wart and Birkedal-Hansen, 1990) and tested
the effect of specific MMP inhibitors. Brief incubation of DIV21
cortical neurons with 0.5 mM APMA for 15 min induced robust
generation of NLG1-NTFs (3.8 ± 0.8-fold increase relative to
control; Figures 3G and 3H). Coincubation with MMP2/MMP9
inhibitor II (0.3 mM) blocked APMA-induced cleavage (0.6 ±
0.1), whereas MMP2 inhibitor III (50 mM) and MMP3 inhibitor III
(50 mM) had no effect (3.8 ± 1.0 and 3.2 ± 0.8, respectively), indi-
cating that MMP9 is the downstream protease responsible for
cleavage of NLG1. To further validate these findings, we tested
how NLG1 is regulated by activity in neurons lacking MMP9.
KCl depolarization of DIV17 and DIV18 wild-type (WT) mouse
cortical cultures for 2 hr resulted in extensive loss of NLG1
(0.36 ± 0.01 relative to control; Figure 3I). By contrast, KCl
incubation of MMP9 KO cultures induced no loss of NLG1
(0.90 ± 0.04 relative to control; Figure 3J), confirming that
MMP9 is responsible for activity-dependent regulation of NLG1.
To characterize the activity-dependent production of NLG1-
CTFs, we measured CTF levels in whole cell extracts of DIV21
dissociated neuron cultures treated with KCl. As expected, KCl
incubation increased NLG1-CTF levels (1.6 ± 0.4 compared to
control; Figures S3E and S3F). Interestingly, inhibition of the
g-secretase complex with DAPT (20 mM) during KCl treatment
resulted in increased accumulation of NLG1-CTFs (KCl+DAPT,
3.7 ± 0.8; Figures S3E and S3F), indicating that NLG1 is pro-
cessed by the g-secretase complex following ectodomain
cleavage.
Extracellular Cleavage of NLG1 Occurs Near Its
Transmembrane Domain
Deglycosylation of NLG1-NTFs produces 70 kDa species
(Figure 2E), which, based on amino acid mass, indicates that
proteolysis occurs in the extracellular juxtamembrane region of
NLG1. To determine the specific domain targeted for cleavage,
we generated a series of mutants with sequential deletions and
amino acid (aa) replacements in the juxtamembrane domain
(Figure 4A). NLG1 mutants were screened for their resistance
to APMA cleavage using biotinylation-based labeling and isola-
tion of NLG1-NTFs in COS7 cells. Brief incubation with APMA
resulted in robust shedding of GFP-NLG1 (Figure 4B). This effect
was blocked by GM6001, confirming that MMPs cleave NLG1
under these conditions (Figure 4B). Substituting 60 aa of the
NLG1 stalk domain (aa 636–695) with the polylinker GAAAAA
resulted in a mutant (NLG1-DSDfull) that is resistant to APMA
(Figures 4A and 4B). Within this 60 residue stretch, deletion of
aa 672–695 (NLG1-DSD3) and replacement with the polylinkerGAAAAA likewise abolished APMA-induced cleavage, whereas
mutation of more membrane-distal sequences did not (aa
636–660, NLG1-DSD1; aa 654–677, NLG1-DSD2). Notably,
we attempted to further resolve the precise cleavage site,
but shorter deletions or single site mutants were all cleaved
upon APMA treatment, potentially due to the presence of
multiple MMP target sequences within this domain. Importantly,
the DSD3 mutation does not alter NLG1 localization, as
GFP-NLG1-DSD3 exhibited a similar distribution pattern and
synaptic enrichment as wild-type GFP-NLG1 when expressed
in DIV21 hippocampal neurons (Figure S4A). Moreover, GFP-
NLG1-DSD3 and GFP-NLG1 induced quantitatively similar
spine formation when expressed in mouse cortical neurons
in vivo from E15.5 to P17 and P18, indicating that GFP-NLG1-
DSD3 retains the synaptogenic properties of wild-type NLG1
(Figures S4D and S4E). To address if NLG1-DSD3 is resistant
to activity-dependent cleavage in neurons, we tested the
effect of KCl depolarization in neurons expressing GFP-NLG1
andGFP-NLG1-DSD3. Following 2 hr of KCl incubation, synaptic
GFP-NLG1 fluorescence decreased to 55.9% ± 5.4% of initial
value, whereas GFP-NLG1-DSD3 exhibited no change upon
KCl treatment (101.9% ± 6.9% of initial fluorescence level;
Figures S4A and S4B).
Rapid Cleavage of NLG1 in Dendritic Spines Following
Local Glutamate Uncaging
To address if NLG1 cleavage occurs locally in response to
increased synaptic activity, we released glutamate at single
dendritic spines by two-photon laser-induced photolysis of
(4-methoxy-7-nitroindolinyl)-glutamate (MNI-glutamate), while
imaging dendrites of neurons expressing GFP-NLG1-WT or
GFP-NLG1-DSD3 (Figures 4C–4L). Analysis was performed in
CA1 pyramidal neurons in organotypic hippocampal slices at
a time corresponding to P14 with tdTomato (tdT) coexpression
used as a cell fill. Stimulation near (1 mm) the distal head of
a dendritic spine (Spine 1) with 80 4-ms laser pulses at 2 Hz
induced rapid loss of spine GFP-NLG1 within 1 min, whereas
no change in fluorescence was detected in the neighboring
dendritic shaft (DGFP/tdT: Spine 1: 0.61 ± 0.04, dendrite:
1.01 ± 0.02; Figures 4C, 4F, and 4J). We observed a smaller,
partial loss of NLG1-GFP in neighboring spines (Spine 2,
DGFP/tdT: 0.79 ± 0.15), possibly due to the diffusion of intra-
cellular signals. Incubation with the MMP2/MMP9 inhibitor II
(0.3 mM) or GM6001 (10 mM) abrogated glutamate-induced
GFP-NLG1 loss (MMP2/MMP9i: DGFP/tdT: Spine 1, 0.89 ±
0.10; Spine 2, 0.97 ± 0.12; dendrite, 0.98 ± 0.11; Figures 4D,
4G, and 4K; GM6001: DGFP/tdT: Spine 1, 0.91 ± 0.04; dendrite,
0.96 ± 0.03; Figures S4F–S4H). Moreover, the cleavage resistant
GFP-NLG1-DSD3 was unaffected by glutamate uncaging
(DGFP/tdT: Spine 1, 0.99 ± 0.05; Spine 2, 0.96 ± 0.11; dendrite,
1.05 ± 0.04; Figures 4E, 4H, and 4L).
Cleavage of NLG1Destabilizes Presynaptic Neurexin-1b
To address how NLG1 cleavage affects synaptic function, we
developed a system to acutely and selectively cleave NLG1
on demand (Figure 5A; Movie S1). For this, we inserted the
thrombin (Thr) proteolytic recognition sequence LVPRGS into
the stalk domain of NLG1 downstream of the dimerizationNeuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc. 401
Figure 4. Local Glutamate Uncaging Triggers Rapid Cleavage of Synaptic NLG1
(A) Model illustrating the NLG1-DSD substitutionmutants in relation to NLG1 domains. AChED, acetylcholinesterase homology domain; DD, dimerization domain;
SD, stalk domain; TM, transmembrane domain; CT, C-terminal domain. Numbers indicate amino acids.
(B) Biotinylation-based cleavage assay of COS7 cells expressing the indicated NLG1 mutants. Total lysates (Lys) or media (Med) were collected and subjected
to immunoblot analysis following treatment with the MMP activator APMA with or without the broad spectrum MMP inhibitor GM6001 (GM). Both NLG1-DSDfull
and NLG-DSD3 were resistant to APMA-induced cleavage, indicating that MMP cleavage sites lie between residues 672 and 695.
(C) Time-lapse images of hippocampal neurons expressing GFP-NLG1 and tdTomato before and after glutamate uncaging. The yellow dot represents the
uncaging spot. ‘‘1’’ represents the dendritic spine stimulated with glutamate and ‘‘2’’ represents a neighboring spine within 10 mm of spine 1. Dashed white line
represents the contour used for fluorescence analysis in (F). Scale bars, 2 mm.
(D) Same as (C), but glutamate uncaging was performed in the presence of MMP2/MMP9 inhibitor II (0.3 mM). Scale bar, 2 mm.
(E) Same as (C), but cells express GFP-NLG1-DSD3 and tdTomato. Scale bar, 2 mm.
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MMP9 Cleaves Neuroligin at Synapsesdomain, replacing the endogenous sequence TTTKVP. In these
experiments, the NLG1DA splice variant lacking splice site A
was chosen, due to its stringent partitioning into excitatory
synapses (Chih et al., 2006). This Thr-cleavable mutant (GFP-
Thr-NLG1) localized to synapses in a manner indistinguishable
from wild-type GFP-NLG1 in DIV21 hippocampal neurons
(Figures 5A–5D). Incubation with 5 U/ml Thr for 30 min resulted
in rapid and extensive reduction of GFP-Thr-NLG1 synaptic
fluorescence (fractional fluorescence remaining; 0.20 ± 0.03;
Figures 5A–5G; Movie S1). Control neurons transfected with
GFP-NLG1 lacking a Thr recognition sequence exhibited no
change in GFP fluorescence upon Thr treatment (fractional
fluorescence remaining; 0.99 ± 0.02; Figure 5H; Movie S2 right
panel), indicating that the reduced GFP fluorescence was not
due to photobleaching. To determine how acute NLG1 shed-
ding affects postsynaptic morphology and integrity, we co-
transfected neurons with mCherry (mCh) or PSD95-mCh and
compared fluorescence changes after 30 min of Thr incuba-
tion. No significant changes in spine volume measured by the
mCh cell fill (mCh fluorescence ratio post/prethrombin; 1.04 ±
0.03; Figures 5A and 5F; Movie S1) or PSD95-mCh puncta
intensity (PSD95-mCh fluorescence ratio post/prethrombin;
0.97 ± 0.02; Figures 5B and 5F) were detected after Thr
treatment.
To test whether acute cleavage of NLG1 regulates presynaptic
NRX1b, we sequentially transfected neuronal cultures with
GFP-Thr-NLG1 and NRX1b-mCh lacking splice site 4, obtaining
distinct populations of neurons expressing each construct. This
approach generated pre- and postsynaptic pairs labeled with
NRX1b-mCh and GFP-Thr-NLG1, respectively. At dually labeled
synapses, acute Thr treatment caused a rapid and pronounced
decrease in NRX1b-mCh fluorescence (Figures 5E–5G; Movie
S2; fractional fluorescence remaining: 0.51 ± 0.04). Further anal-
ysis of the kinetics of GFP-Thr-NLG1 and NRX1b-mCh level at
a higher sampling rate revealed that loss of both proteins occurs
in tandem (Figures S5A–S5D). Importantly, there was no detect-
able change in presynaptic synaptophysin-mCh signal intensity
(fractional fluorescence remaining: 0.99 ± 0.08) under similar
conditions (Figures 5D and 5F), indicating that destabilization
of NRX1b by NLG1 cleavage is specific and not due to indirect
structural changes in presynaptic terminals. This was further
confirmed by immunolabeling of the vesicular glutamate trans-
porter VGLUT1, which was unaffected by acute NLG1 cleavage
(Figures S5E–S5G).
NLG1 Cleavage Decreases Synaptic Strength by
Reducing Presynaptic Release
To define the physiological effects induced by acute NLG1
cleavage, we used whole-cell electrophysiological recordings
to measure synaptic transmission on DIV15–DIV25 hippo-
campal neurons expressing GFP-Thr-NLG1 for 3–5 days. This(F–H) Fluorescence intensity profiles of GFP (green) and tdTomato (red) along th
(I) Representation of the dendrite segment depicted in (E), illustrating analysis of G
regions.
(J–L) Means ± SEMs of GFP/tdTomato fluorescence intensity ratio after glutam
conditions represented in (C–E), respectively. n = 10, 11, and 11; *p < 0.05, **p <
See also Figure S4.system allowed us to monitor synaptic transmission in the
same neuron before and after selective Thr-induced cleavage
of NLG1. Recordings from neurons expressing GFP-NLG1 lack-
ing a Thr cleavage site were used to control for possible off-
target effects of Thr activity. We first examined the effect of
NLG1 cleavage on miniature excitatory postsynaptic currents
(mEPSCs; Figure 6A). Application of Thr for 30 min reduced
mEPSC frequency (44% ± 10% of baseline; Figures 6B and
S6A) with no significant effect on amplitude (91% ± 8% of base-
line; Figures 6C and S6A), indicating that NLG1 ectodomain
cleavage does not change postsynaptic AMPA receptor number
or function, but rather reduces neurotransmitter release or
decreases the number of functional excitatory synapses. By
contrast, Thr had no effect on mEPSCs in neurons expressing
GFP-NLG1 (mEPSC frequency, 100% ± 3% of baseline;
amplitude, 102% ± 4% of baseline; Figures 6A–6C and S6B).
Importantly, there was no difference in baseline mEPSCs
between neurons expressing GFP-NLG1 (frequency: 1.74 ±
0.44 s1; amplitude: 11.66 ± 1.70 pA) and GFP-Thr-NLG1
(frequency: 2.00 ± 0.36 s1; amplitude: 10.74 ± 0.61 pA).
Consistent with the predominant localization of NLG1 to gluta-
matergic synapses (Chubykin et al., 2007; Graf et al., 2004),
NLG1 cleavage failed to alter miniature inhibitory postsynaptic
current (mIPSC) frequency or amplitude (mIPSC frequency:
103 ± 3%; mIPSC amplitude: 98% ± 8% of baseline; Figures
S6C–S6F), indicating that NLG1 cleavage does not acutely alter
GABAergic transmission.
The reduction in mEPSC frequency (Figures 6A, 6B, and S6A)
together with the destabilization of NRX1b (Figures 5C–5G)
suggested a possible alteration in presynaptic function. To test
this further, we examined the effects of Thr-induced NLG1
cleavage on evoked excitatory synaptic currents (eEPSCs) and
their paired-pulse responses. Evoked responses were elicited
by stimulating nearby cells with an interstimulus interval of
100 ms. Neurons expressing GFP-NLG1 or GFP-Thr-NLG1 ex-
hibited similar baseline paired-pulse ratio (PPR) responses
(GFP-NLG1: 1.42 ± 0.12; GFP-Thr-NLG1: 1.59 ± 0.46). Record-
ings were then made on the same cell before and 30 min after
thrombin application. Thrombin treatment of neurons expressing
GFP-Thr-NLG1 reduced the amplitude of the first response and
increased PPR (eEPSC amplitude: 50% ± 18% of baseline; PPR:
139%± 8%of baseline; Figures 6D–6F), strongly suggesting that
NLG1 cleavage decreases the probability of neurotransmitter
release. This effect was not attributable to Thr treatment per
se, as there was no change in eEPSC amplitude or PPR in
neurons expressingGFP-NLG1 lacking a Thr cleavage sequence
(eEPSC amplitude: 95% ± 8% of baseline; PPR: 106% ± 6% of
baseline; Figures 6D–6F).
To address whether specific blockade of NLG1 cleavage
also alters release probability, we expressed GFP-NLG1 or
GFP-NLG1-DSD3 in DIV17 hippocampal neurons ande white dashed lines depicted in (C–E).
FP and tdTomato fluorescence in dendritic spines and adjacent dendritic shaft
ate uncaging in dendritic spines and adjacent dendritic shaft regions in the
0.001.
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Figure 5. Juxtamembrane Cleavage of Neuroligin Destabilizes Presynaptic Neurexin-1b
(A) Left, schematic of thrombin-cleavable NLG1. Right, DIV21 hippocampal neurons expressing GFP-Thr-NLG1 and mCherry for 3–5 days were imaged before
(Pre) and 30 min after (Post) thrombin incubation. Scale bar, 5 mm.
(B) Same as (A), but neurons expressed GFP-Thr-NLG1 and PSD95-mCh. Scale bar, 5 mm.
(C) Dually labeled synapses with postsynaptic GFP-Thr-NLG1 and presynaptic NRX1b-mCh imaged by confocal microscopy before (Pre) and 30 min after (Post)
thrombin incubation. Solid arrowheads show loss of presynaptic NRX1b-mCh apposed to postsynaptic GFP-Thr-NLG1 puncta. Open arrowheads show
generation of mobile NRX1b-mCh puncta along the axon. Scale bar, 5 mm.
(D) Same as (C), but cells were cotransfected with GFP-Thr-NLG1 and synaptophysin-mCh (Sph-mCh). Sph-mCh is not affected GFP-Thr-NLG1 cleavage.
Scale bar, 5 mm.
(E) Time lapse of the highlighted region depicted in (C). The red arrowhead shows the time of thrombin (Thr) application. Scale bar, 5 mm.
(F) Means ± SEMof fluorescence intensity change 30min after thrombin (Thr) cleavage at synapses expressing GFP-Thr-NLG1.mCherry, n = 307 spines; PSD95-
mCh, n = 403 spines; Sph-mCh, n = 43 synaptic pairs; NRX1b-mCh, n = 87 synaptic pairs, *p < 0.05.
(G) Fluorescence intensity before and after thrombin application at synapses containing presynaptic NRX1b-mCh and postsynaptic GFP-Thr-NLG1. Arrowhead
shows time of thrombin (Thr) application. n = 87 synaptic pairs.
(H) Same as (G), but neurons expressed GFP-NLG1 lacking a thrombin cleavage site. n = 76 synaptic pairs.
See also Figure S5 and Movies S1 and S2.
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MMP9 Cleaves Neuroligin at Synapsescompared FM4-64 unloading kinetics from contacting presyn-
aptic terminals at DIV21 (Figures 6G–6I). To increase basal
rate of NLG1 cleavage, cultures were incubated with bicucul-
line (50 mM) and 4AP (25 mM) 2 days prior to imaging (Figures
3A and 3B). Interestingly, terminals apposing synapses with404 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.GFP-NLG1-DSD3 exhibited faster FM4-64 unloading kinetics
(t = 46.1 ± 1.2 s; Figure 6G) than terminals contacting GFP-
NLG1-expressing cells (t = 60.5 ± 1.5 s), indicating that
blocking NLG1 cleavage increases presynaptic release
probability.
Figure 6. NLG1 Cleavage Rapidly Reduces Release Probability at
Excitatory Synapses
(A) Miniature EPSCs (mEPSCs) recorded before (Baseline) and 30 min after
(Post) thrombin treatment in hippocampal neurons (DIV15–DIV25), expressing
GFP-Thr-NLG1 or GFP-NLG1.
(B) Means ± SEM of mEPSC frequency and (C) amplitude change after
thrombin incubation in neurons expressing GFP-NLG1 or GFP-Thr-NLG1. n =
8 and 5 for GFP-Thr-NLG1 and GFP-NLG1, respectively. *p < 0.01.
(D) Paired-pulse EPSCs recorded before (Baseline) or 30 min after (Post)
thrombin treatment in hippocampal neurons (DIV15–DIV25), expressing GFP-
Thr-NLG1 or GFL-NLG. Insets depict traces before and after thrombin treat-
ment, normalized to the amplitude of the first excitatory postsynaptic potential.
(E) Means ± SEM of eEPSC amplitude change after thrombin in neurons
expressing GFP-NLG1 or GFP-Thr-NLG1. n = 6 and 6; *p < 0.05.
(F) Means ± SEM of paired-pulse ratio change after thrombin in neurons
expressing GFP-NLG1 or GFP-Thr-NLG1. n = 6 and 6; *p < 0.05.
(G) Means ± SEM of time constants (t) from stimulus-induced FM4-64 fluo-
rescence decay measurements in presynaptic terminals apposing neurons
expressing GFP-NLG1 or GFP-NLG1-DSD3. Terminals apposing GFP-NLG1-
DSD3 synapses exhibit faster FM4-64 decay kinetics. GFP-NLG1-DSD3, n =
396 terminals, 12 neurons; GFP-NLG1, n = 438 terminals, 11 neurons; ***p <
0.0001.
(H) Cumulative distribution of FM4-64 decay constants (t) of terminals
analyzed in (G).
(I) Representative kymographs of FM4-64 intensity in terminals apposing
GFP-NLG1 or GFP-NLG1-DSD3. Arrowhead indicates time of KCl application.
See also Figure S6.
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MMP9 Cleaves Neuroligin at SynapsesNLG1 Is Cleaved by MMP9 in Response to Increased
Neuronal Activity in Mature and Developing Circuits
To address whether cleavage of NLG1 is regulated by activity
in vivo, we measured NLG1-NTFs generated during pilocar-
pine-induced status epilepticus (PSE) in mice. Intraperitoneal
administration of pilocarpine in P60 mice induced robust
seizures and resulted in a 2.2 ± 0.3-fold increase of soluble
NLG1-NTFs in the hippocampus after 2 hr PSE (Figures 7A–
7C). To test whether MMP9 is involved in PSE-induced NLG1
cleavage, we performed pilocarpine injections in MMP9 KO
mice. Notably, 2 hr PSE characterized by robust behavioral
seizures failed to elevate soluble NLG1-NTFs in MMP9 KO
hippocampus (1.1 ± 0.1 relatively to control; Figures 7B and
7C). As a control for epileptic activity, both WT and MMP9 KO
mice exhibited upregulation of the activity-regulated protein
Arc/Arg3.1 after PSE (Figure 7B).
Given the enrichment of NLG1-NTFs during the first postnatal
weeks (Figures 2G and 2H), we addressed whether NLG1
cleavage is regulated by sensory experience during develop-
ment. For this, we subjected mice to 5 days of dark rearing
(DR) from P21–P26, a period of heightened sensory-evoked
refinement of visual cortical circuits (Hensch, 2004), and subse-
quently re-exposed them to light for a brief period of 2 hr
(DR+2hL, Figure 7D). This protocol induces rapid synaptic
remodeling in the visual cortex and results in extensive molec-
ular, functional, and structural synaptic changes (Philpot et al.,
2001; Tropea et al., 2010). With this paradigm, 2 hr of re-expo-
sure to light after 5 days of DR caused an increase in NLG1
cleavage in the visual cortex of WT mice (DR: 1.0 ± 0.1;
DR+2hL: 1.5 ± 0.2, relatively to light-reared (LR) group; Figures
7E and 7F), but not in MMP9 KO animals (DR: 0.9 ± 0.1;
DR+2hL: 1.0 ± 0.1; relative to LR group). Together these findings
indicate that increased neuronal activity in vivo triggers MMP9-
dependent cleavage of NLG1 in both mature and developing
circuits.
DISCUSSION
Cleavage and Loss of Neuroligin-1 from Synapses
Although implicated in diverse forms of activity-dependent
synaptic maturation and plasticity (Choi et al., 2011; Chubykin
et al., 2007; Jung et al., 2010), it has been unclear whether neuro-
ligins acutely regulate synapse function and whether the neuro-
ligin-neurexin transsynaptic complex undergoes dynamic disso-
ciation. Here we have shown that increased neuronal activity
decreases synaptic NLG1 in minutes. MMP inhibitors, but not
lysosome or proteasome inhibitors, block this effect, indicating
that, under these conditions, NLG1 is predominantly regulated
by MMP proteolytic cleavage (Figures 1G and 1H). The extent
of endogenous NLG1 loss from synapses observed using
biochemical methods is greater than that observed by
immunostaining (Figure 1). This disparity may be attributed to
the broad specificity of the pan-NLG antibody used for immu-
nolabeling and to the fact that it targets the C-terminal domain
of NLGs, an epitope that is further regulated by the g-secretase
complex (Figures S3E and S3F). It will be important to address
how other NLG isoforms are regulated by MMPs and whether
NLG1-CTFs participate in intracellular signaling.Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc. 405
Figure 7. NLG1 Cleavage Is Triggered by
Neural Activity and Sensory Experience
In Vivo
(A) WT and MMP9 KO mice were injected with
pilocarpine (315 mg/kg) or saline (control) for 2 hr.
(B) Immunoblot analysis of total extracts (5 mg)
and soluble fractions (Sol, 50 mg) of hippocampi
from mice injected with pilocarpine or saline
(control). Arrow indicates increased NLG1-NTFs
after PSE in WT mice.
(C) Means ± SEMs of NLG1-NTFs levels in
indicated conditions normalized to control. n = 9
animals in each WT group; n = 10 and 11 in MMP9
KO control and pilocarpine groups, respectively.
*p < 0.005.
(D) WT and MMP9-KO mice were reared in
a normal 12 hr day/night cycle (LR) for 26 days
or submitted to dark rearing for 5 days from P21–
P26 (DR). DR+2hL indicates group submitted to
2 hr light exposure (yellow box) after DR.
(E) Immunoblot analysis of primary visual cortex
soluble fractions of P26 mice reared under
different conditions. a-actinin (a-Act) was used as
a loading control.
(F) Means ± SEM of NLG1-NTFs levels under
different conditions normalized to LR groups. n =
27 animals in each WT group; n = 24, 25, and
28 animals in MMP9 KO LR, DR, and DR+2hL
groups, respectively. *p < 0.01.
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MMP9 Cleaves Neuroligin at SynapsesMultiple soluble NLG1-NTF species can be detected in the
brain (Figure 2D), suggesting that NLG1 contains more than
one cleavage site. This observation provides a plausible expla-
nation for why single amino acid point mutations in the juxta-
membrane region of NLG1 fail to prevent MMP-dependent
cleavage, which instead requires substitution of a 24 amino
acid segment (Figures 4A and 4B). Moreover, basal levels of
NLG1-NTFs can be detected in brain extracts from MMP9 KO
mice (Figure 7B), indicating the existence of MMP9-independent
mechanisms cleaving NLG1. In addition, our data indicate that
NLG1-NTFs are most abundant during the first postnatal weeks
(Figures 2G and 2H), suggesting that NLG1 cleavage may have
different functions during development. It will be important to
define in detail the activity-independent andMMP9-independent
mechanisms of NLG1 cleavage and their specific role in synapse
development and plasticity. Nevertheless, our results indicate
that MMP9 is required for activity-dependent cleavage of
NLG1 in multiple cellular contexts in vivo (Figure 7) and in vitro
(Figures 3 and 4), consistent with the known involvement of
MMP9 in multiple forms of synaptic plasticity (Bozdagi et al.,
2007; Nagy et al., 2006; Szklarczyk et al., 2002; Wang et al.,
2008; Wilczynski et al., 2008).
Focal uncaging of glutamate triggers MMP9-dependent
cleavage of postsynaptic NLG1, indicating that this mechanism
is regulated locally (Figures 4C and 4J). Interestingly, we de-
tected a small heterosynaptic decrease of GFP-NLG1 from
neighboring dendritic spines after synaptic stimulation (Figures
4C and 4J), suggesting that MMP9 activation may spread to406 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.adjacent dendritic regions. It remains unclear how NMDAR/
CaMK signaling couples to MMP9 activity; however, considering
the presence of MMP9 in spino-dendritic tubulovesicular
structures (Wilczynski et al., 2008), one possibility is that CaMK
activation triggers exocytosis of MMP9-containing vesicles in
nearby dendritic regions or spines (Kennedy and Ehlers, 2011).
It will be interesting to address if persistent cleavage of NLG1
can induce dendrite-wide effects and how the surface pools of
NLGs are redistributed and replenished following periods of
increased MMP-9 activity.
Neuroligin Cleavage as a Transsynaptic Retrograde
Signal
Acute ectodomain cleavage of postsynaptic NLG1 causes rapid
loss of NRX1b from apposing presynaptic terminals (Figures 5C,
5E, and 5G). The presynaptic protein synaptophysin is not
affected by NLG1 cleavage, indicating that shedding of NLG1
is not accompanied by gross structural changes in presynaptic
terminals (Figures 5D and 5F). Considering the expanding set
of transsynaptic NRX binding partners, these results suggest
that postsynaptic NLG1 is an important regulator of NRX1b
stability at synapses. Previous studies have shown that deletion
of aNRXs in mice reduces action-potential-evoked neuro-
transmitter release due to impaired presynaptic Ca2+ channel
function (Missler et al., 2003). However, due to the role of
NRXs in synapse maturation, it has been unclear whether this
effect is due to indirect developmental effects or reflects an
ongoing role of NRXs in neurotransmitter release. Using the
Neuron
MMP9 Cleaves Neuroligin at Synapseshighly selective thrombin-induced cleavage of NLG1, we show
an overall reduction in excitatory transmission and release
probability concurrent with NRX1b loss (Figure 6). These findings
support the notion that the NLG-NRX complex is a critical regu-
lator of neurotransmitter release (Futai et al., 2007; Missler et al.,
2003; Zhang et al., 2005) and provide evidence that NLG1-
dependent regulation of presynaptic function can occur over
time scales of minutes.
In mature hippocampal and cortical cultures, postsynaptic
receptor blockade increases mEPSC frequency (Burrone et al.,
2002; Thiagarajan et al., 2005; Wierenga et al., 2006) and
augments presynaptic terminal size and release probability
(Murthy et al., 2001; Thiagarajan et al., 2005). By contrast, local
stimulation of dendrites acutely reduces release probability of
contacting presynaptic terminals (Branco et al., 2008). These
data have implied the existence of local transsynaptic negative
feedback signals capable of modifying presynaptic function
based on postsynaptic activity. Our results indicate that NLG1
cleavage is bidirectionally regulated by activity (Figures 3A and
3B). Moreover, acute NLG1 cleavage decreases release proba-
bility, whereas expression of a cleavage-resistant NLG1 isoform
induces the opposite effect (Figure 6). Together, these data
support a model where increased or decreased local NLG1
cleavage alternately dampens or augments presynaptic function
based on postsynaptic activity, thereby contributing to overall
levels of neuronal excitability.
MMP9-Dependent Cleavage of Neuroligin-1
in Development and Disease
The developmental profile of NLG1-NTFs in the brain (Figures 2G
and 2H) indicates that NLG1 cleavage is upregulated during
early stages of development, a time when activity-dependent
mechanisms sculpt new circuits (Hensch, 2004). Moreover, our
results indicate that MMP9-dependent cleavage of NLG1 is
regulated by sensory experience during visual cortex matura-
tion (Figures 7E and 7F). Interestingly, tissue plasminogen
activator, a robust activator of MMP9 (Wang et al., 2003),
regulates synapse maintenance during cortical development
(Mataga et al., 2004), whereas MMP9 inhibition accelerates
spine maturation in cultures (Bilousova et al., 2009). It will be
interesting to address if NLG1 cleavage is involved in the
activity-dependent mechanisms underlying synaptic matura-
tion during development.
In addition, MMP9-dependent cleavage of NLG1 is increased
during status epilepticus in the hippocampus of adult mice,
indicating that this mechanism occurs in vivo not only during
development, but also in mature circuits. Interestingly, MMP9
is upregulated and activated during seizures and, in turn,
induces extensive synaptic plasticity and remodeling of hippo-
campal circuits (Szklarczyk et al., 2002; Wilczynski et al.,
2008). Although our results indicate that postsynaptic structure
and function remain largely unaffected following NLG1 cleavage
(Figures 5A, 5B, and 5F; Movie S1), it remains to be determined
whether further processing or long-term loss of NLG1 can
impact postsynaptic function and stability. Finally, several NLG
and NRX mutations have been linked to autism spectrum
disorders (ASDs) (Su¨dhof, 2008). In humans, ASDs emerge
during the first years of infancy and are often associated withepileptic disorders. Our results implicate NLG1 cleavage with
epileptiform activity and maturation of developing neuronal
circuits. The acute proteolytic regulation of neuroligins reported
here may provide novel insight into the pathophysiological
mechanisms and therapeutic strategies for synaptic dysfunc-
tion in ASDs. More broadly, such a mechanism may provide
a general paradigm for transsynaptic signaling in diverse neural
circuits.EXPERIMENTAL PROCEDURES
DNA Constructs and Antibodies
PSD95-mCh was a gift from Thomas Blanpied (University of Maryland).
mCherry-N1 vector was a gift from Roger Tsien (University of California, San
Diego). Rat GFP-NLG1 in pcDNA3 (DA splice variant) was kindly provided by
Ann Marie Craig (University of British Columbia), and NRX1b-mCh was a gift
from Thomas Su¨dhof (Stanford University). Antibodies are listed in Supple-
mental Experimental Procedures.Biochemical Analysis of Brain, Whole Cell Extracts, and PSD
Fractions
Whole cell, synaptic plasma membrane, and PSD fractions from high density
neuronal cultures were prepared and analyzed as described previously
(Ehlers, 2003).Surface Biotinylation and Isolation of Soluble Cleavage Products
Biotinylation-based internalization assays was performed as described
previously (Ehlers, 2000). For isolation of soluble cleavage products,
DIV21 cortical cultures were incubated in PBS/Ca2+ with 1 mg/ml Sulfo-
LC-Biotin-NHS (Pierce) for 10 min at 37C. Cultures were washed in
PBS/Ca2+ with 10 mM Tris (pH 7.4), rinsed 23 in PBS/Ca2+, and incubated
in conditioned media at 37C for the indicated time period. Pharmacolog-
ical inhibitors were added 5 min prior to manipulations of neuronal activity.
After incubation, culture media was collected, supplemented with protease
inhibitors (Roche), and centrifuged at 16,000 3 g for 20 min. For surface-
labeled controls, cultures were washed 23 with PBS/Ca2+, immediately
lysed with precipitation buffer (PBS with 1% Triton X-100, 5 mM EDTA,
10 mM L-lysine [pH 7.4]), sonicated, and centrifuged at 16,000 3 g for
20 min. Supernatants were incubated overnight with 50 ml NeutrAvidin
Plus UltraLink Resin (Pierce) at 4C. For NMDA stimulation, cells were incu-
bated in media containing 50 mM NMDA for 5 min and subsequently incu-
bated in conditioned media for 2 hr. Both media samples were pooled before
streptavidin precipitation. For all samples, precipitated proteins were boiled
in 23 sample buffer and resolved by SDS-PAGE prior to immunoblot anal-
ysis. For APMA experiments, 50 mM APMA stock was solubilized in 0.1 N
NaOH and added at a final concentration of 0.5 mM to culture media,
together with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES) (pH 7.4).In Utero Electroporation
E15.5 timed-pregnant C57BL/6 mice were anesthetized by 2% isoflurane.
Uterine horns were gently mobilized from the peritoneal cavity and 1 mg/ml of
GFP-NLG1 or GFP-NLG1-DSD3, and tdTomato cDNAs were injected into
the lateral ventricle of the left hemisphere of intrauterine embryos using an
50-mm-diameter pipette sharply beveled at 15–20 (Narishige, Japan).
DNA was transfected with five electrical pulses with a 1 s interval (50 V,
50 ms) (CUY21 electroporator, NEPA GENE, Japan).Slice Culture Preparation
Organotypic hippocampal slice cultures were prepared from 8-day-old mice
and cut with 400 mm thickness. Three to five slices were placed in a sterile
culture plate insert (Millicell-CM, Millipore). DNA constructs were biolistically
transfected with a Helios Gene Gun (Biorad) 2 days later.Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc. 407
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MMP9 Cleaves Neuroligin at SynapsesTwo-Photon Microscopy and Glutamate Uncaging
Uncaging of MNI-glutamate and spine/dendrite imaging were performed
using a custom-built microscope combining two-photon laser-scanning
microscopy and two-photon laser photoactivation, as previously described
(Kwon and Sabatini, 2011). Organotypic or acute brain slices were placed in
a slice chamber perfused with normal artificial cerebrospinal fluid containing
(in mM) 127 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2,
and 25 glucose. Dendrite/spine images were acquired with 840 nm excita-
tion wavelength, and photolysis of MNI-glutamate was performed by focal
illumination with 720 nm light. The laser power arriving at the specimen
(1015 mW) was controlled by Pockels cells (Conoptics, Danbury, CT).
Uncaging was done 1 mm away from the spine head and 80 laser pulses
(4 ms) were delivered at 2 Hz. Spine/dendrite image stacks were taken imme-
diately before and after the induction protocol (<1 min). To analyze changes
of GFP-NLG1, green fluorescence (G) measured in the spine head or sub-
jacent dendrite was normalized to the red signal (R) from the same area and
changes in the G/R ratios compared before and after the induction protocol.
Confocal Imaging and FM4-64 Unloading Experiments
Confocal images of fixed samples and live cells were obtained using a Perkin
Elmer Ultraview spinning disc confocal microscope with either a 403 1.3 N.A.
objective or a 60 3 1.4 N.A. objective. For immunocytochemistry, DIV21
hippocampal neurons were fixed in 4% paraformaldehyde/4% sucrose
in PBS for 20 min, permeabilized with 0.2% Triton X-100 for 15 min, and
incubated with indicated antibodies. For live imaging, cells were imaged in
E4 media containing (in mM) 10 HEPES, 120 NaCl, 3 KCl, 10 D-glucose,
2 CaCl2, and 2 MgCl2 at 37
C. Maximum projections of individual stacks
were analyzed using Metamorph software (Universal Imaging Corporation).
Results shown correspond to the average of all neurons per condition. Statis-
tical significance was determined by unpaired t test, and error bars represent
standard error of the means.
FM4-64 (10 mM) uptake was performed using 90mMKCl loadingmedia con-
taining (in mM) 10 HEPES, 33 NaCl, 90 KCl, 10 D-glucose, 2 CaCl2, 2 MgCl2,
20 mM NBQX, and 50 mM APV for 1 min. Cells were washed three times in
washing buffer (WB: E4 with 0.5 mM CaCl2 and 10 mM MgCl2) for 30 s, two
times for 15 s in WB containing 1 mM ADVASEP-7 (Sigma), and three times
in WB. FM4-64 fluorescence was acquired with 567 nm excitation and
a 647 nm emission filter. GFP imaging was done at the end of each time lapse
to minimize photobleaching. Unloading solution containing (in mM) 10 HEPES,
63NaCl, 60 KCl, 10 D-glucose, 2 CaCl2, 2MgCl2, 20 mMNBQX, and 50 mMAPV
was added with a precision of <2 s. Time constants (t) of FM4-64 fluorescence
decay at boutons corresponding to each condition were pooled and ana-
lyzed by a Kolmogorov-Smirnov test. Statistical significance was determined
using unpaired t tests. For more details, see Supplemental Experimental
Procedures.
Electrophysiological Recordings
EPSC internal solution contained (in mM) 30 CsSO4, 70 K2SO4, 25 HEPES,
25 N-methyl-D-glucamine, 0.1 CaCl2, 1 EGTA, 2 (Na)ATP, and 0.1 leupeptin
(pH 7.2), 300 mOsm, and EPSC external solution contained (in mM) 150
NaCl, 5 KCl, 10HEPES, 1MgCl2, 30D-glucose, 2CaCl2, and 30 mMbicuculline.
Only cells with series resistance <30MU and <20%change in input resistance,
series resistance, and holding current were analyzed. EPSCswere evokedwith
a concentric bipolar stimulating electrode (200 ms pulse duration). Paired-pulse
responses (100 ms interval) were evoked every 30 s by stimulation of nearby
cells. For mEPSC recordings, external solution contained additional 1 mM
TTX. mIPSC internal solution contained (in mM) 150 KCl, 3 MgCl2, 15 HEPES,
0.1 CaCl2, 1 EGTA, 2 Na2ATP, and 0.1 leupeptin [pH 7.2],300mOsm. mIPSC
external solution contained 1 mMTTX, 50 mMD-APV, and 10 mMCNQX instead
of bicuculline. All currents were recorded at 70 mV voltage clamp.
Pilocarpine-Induced Status Epilepticus
P60 female FVB or FVB.Cg-Mmp9tm1Tvu/J mice (18–25 g) were injected
intraperitoneally (i.p.) with 1 mg/kg scopolamine methyl nitrate (Sigma)
30 min prior to the experiment. Status epilepticus was induced by i.p. injection
of 315 mg/kg pilocarpine hydrochloride (Sigma), while controls were injected
with vehicle alone (sterile 0.9% NaCl). The experiment was terminated 2 hr408 Neuron 76, 396–409, October 18, 2012 ª2012 Elsevier Inc.later, and hippocampal tissue was collected and flash frozen. Only animals
with class IV or higher seizures were used for analysis.
Dark Rearing Experiments
Male and female FVB or FVB.Cg-Mmp9tm1Tvu/J mice were reared in a normal
light dark cycle (12 hr light/12 hr dark) from birth until P26 (LR) or were trans-
ferred to a dark room in complete darkness at P21 (DR). The DR+2hL group
was re-exposed to light for 2 hr before euthanization. The primary visual cortex
was extracted and homogenized as described previously (Philpot et al., 2001).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2012.07.006.
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